MedTrace Logo

Precise Percutaneous Coronary Intervention Plan (P3) Study

NCT03782688 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2023-03-23

No results posted yet for this study

Summary

The PRECISE PERCUTANEOUS CORONARY INTERVENTION (PCI) PLAN STUDY is an investigator-initiated, international and multicenter study of patients with an indication for PCI aiming at assessing the agreement and accuracy of the HeartFlow Planner with invasive fractional flow reserve (FFR) as a reference.

Conditions

  • Stable Coronary Artery Disease

Interventions

DIAGNOSTIC_TEST

FFRCT planner

Non-invasive post-PCI fractional flow reserve prediction

Sponsors & Collaborators

  • Onze Lieve Vrouw Hospital

    lead OTHER

Principal Investigators

  • Bernard De Bruyne, MD, PhD · OLV-Aalst

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2020-12-18
Completion
2021-12-18

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03782688 on ClinicalTrials.gov